Tilray Brands (TLRY) Net Cash Flow (QoQ) (2017 - 2026)
Tilray Brands (TLRY) Net Cash Flow (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Tilray Brands | - | - | 54.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 110.02% |
| Nov 30, 2025 | -142.91% |
| Aug 31, 2025 | 147.60% |
| May 31, 2025 | 42.37% |
| Feb 28, 2025 | 192.04% |
| Nov 30, 2024 | 45.06% |
| Aug 31, 2024 | -129.11% |
| May 31, 2024 | 4,461.29% |
| Feb 29, 2024 | 105.30% |
| Nov 30, 2023 | -21.93% |
| Aug 31, 2023 | -166.54% |
| May 31, 2023 | 264.61% |
| Feb 28, 2023 | 91.43% |
| Nov 30, 2022 | -494.97% |
| Aug 31, 2022 | -44.41% |
| May 31, 2022 | 357.39% |
| Feb 28, 2022 | -20.11% |
| Nov 30, 2021 | 59.85% |
| Aug 31, 2021 | -137.30% |
| Nov 30, 2020 | -184.22% |